Researchers unfold the mechanisms underlying blood disorders

Jul 23, 2012

A Finnish research team together with researchers from New York, USA, has uncovered a protein structure that regulates cell signalling and the formation of blood cells.

The team’s results, published in Nature Structural & Molecular Biology, the most prestigious journal in the field, shed light on the mechanisms at play in haematological disorders and provide new opportunities for the design of disease-specific treatment. The work was carried out with funding from the Academy of Finland, the Cancer Society of Finland, National Institutes of Health and the Sigrid Jusélius Foundation.

Blood cell formation and activity is regulated by cytokines, small cell-signalling protein molecules, through a signal pathway mediated by Janus kinases (JAKs), a family of enzymes. Previous studies have shown that mutations in JAKs can cause severe haematological disorders as well as immunological diseases. These mutations are concentrated in the pseudokinase domain.

Leading laboratories and pharmaceutical companies around the world have long aimed at defining the structure of the pseudokinase domain of JAKs, as it has been found to be a veritable hotspot for pathogenic mutations causing haematological disorders. Led by Professor Olli Silvennoinen, the Finnish research team has now successfully determined the three-dimensional atomic-level structure of both the normal and the pathogenic pseudokinase domain.

Professor Silvennoinen’s team is the first to describe the structure of the pseudokinase domain of JAKs, laying bare the domain’s enzymatic mechanisms at the atomic level. The team also managed to determine the structural change, caused by the JAK2 V617F mutation, which gives rise to common myeloproliferative diseases (MPDs), such as polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF). PV and ET are blood disorders characterised by an overproduction of red or platelets, whereas MF is a disorder that causes scar tissue to accumulate in the bone marrow. The team’s research results can be put to good use in developing new, targeted therapeutics for these .

The study now published in Nature Structural & Molecular Biology builds on the long-standing expertise of Professor Silvennoinen’s team in Janus kinases. In the early 1990s, while working in the US, Silvennoinen successfully cloned the JAK2 gene and demonstrated its activity in the signalling pathways of erythropoietin and interferon. In Finland, the Silvennoinen’s work focused on the pseudokinase domain, determining and characterising its regulatory function.

The present study was carried out in close collaboration with New York University and Columbia University.

Explore further: Two-armed control of ATR, a master regulator of the DNA damage checkpoint

More information: Rajintha M. Bandaranayake, Daniela Ungureanu, Yibing Shan, David E. Shaw, Olli Silvennoinen and Stevan R. Hubbard: “Crystal structures of the Jak2 pseudokinase domain and the pathogenic mutant V617F”. Nature Structural & Molecular Biology.

add to favorites email to friend print save as pdf

Related Stories

Genetic abnormality may increase risk of blood disorders

Mar 15, 2009

Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have shown for the first time that a tendency to develop some blood disorders may be inherited. Their research, published online today in Nature Genetics, identi ...

Protein shows talent for improvisation

Apr 21, 2008

Radio and cable are not required for communication within and between living cells. Rather, signal transduction in cells is performed by a multitude of proteins. In order to transfer and interpret these signals correctly, ...

Recommended for you

Japanese scientist resigns over stem cell scandal

Dec 19, 2014

A researcher embroiled in a fabrication scandal that has rocked Japan's scientific establishment said Friday she would resign after failing to reproduce results of what was once billed as a ground-breaking study on ...

'Hairclip' protein mechanism explained

Dec 18, 2014

Research led by the Teichmann group on the Wellcome Genome Campus has identified a fundamental mechanism for controlling protein function. Published in the journal Science, the discovery has wide-ranging implications for bi ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.